Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Beijing Normal University manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 3 distinct examiners and 3 distinct art units. This creates a direct alignment where each pending action is reviewed by a unique examiner in a unique art unit within the biotechnology field.
The busiest examiner, YESILDAG, MEHMET, is responsible for 1 pending office action. Every examiner in this portfolio currently handles exactly 1 pending action. This distribution requires the university to navigate 3 different examiner perspectives across 3 separate art units simultaneously, as no single examiner oversees multiple files.
The involvement of 3 distinct art units suggests that the university's biotechnology filings cover a variety of specialized sub-sectors. Practitioners must tailor their prosecution strategies to the specific standards of each of the 3 distinct examiners. The lack of overlap between examiners means that successes or setbacks in one matter may not directly influence the others across the 3 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YESILDAG, MEHMET | 1 | 33.7% | +28.3% |
| KOROTCHKINA, LIOUBOV G | 1 | 29.0% | +64.1% |
| CRAIG, KAILA ANGELIQUE | 1 | 33.8% | +25.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19204733 | HEALTH ASSESSMENT METHOD OF AN AQUATIC ECOSYSTEM BASED ON ECOLOGICAL INTEGRITY AND AN APPLICATION THEREOF | YESILDAG, MEHMET | — |
| 18225937 | INTERPENETRATING NETWORK MICROBIAL HYDROGEL WITH NATURAL POLYSACCHARIDE AND PROTEIN AND PREPARATION METHOD THEREOF | KOROTCHKINA, LIOUBOV G | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19204733 | HEALTH ASSESSMENT METHOD OF AN AQUATIC ECOSYSTEM BASED ON ECOLOGICAL INTEGRITY AND AN APPLICATION THEREOF | YESILDAG, MEHMET | — |
| 18225937 | INTERPENETRATING NETWORK MICROBIAL HYDROGEL WITH NATURAL POLYSACCHARIDE AND PROTEIN AND PREPARATION METHOD THEREOF | KOROTCHKINA, LIOUBOV G | — |
| 17287642 | DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO A BETA PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF | CRAIG, KAILA ANGELIQUE | — |
| Art Unit | Apps |
|---|---|
| 3624 | 1 |
| 1653 | 1 |
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19204733 | HEALTH ASSESSMENT METHOD OF AN AQUATIC ECOSYSTEM BASED ON ECOLOGICAL INTEGRITY AND AN APPLICATION THEREOF | YESILDAG, MEHMET | 3624 | §101 | Non-Final OA | — | Pending | May 12, 2025 |
| 18225937 | INTERPENETRATING NETWORK MICROBIAL HYDROGEL WITH NATURAL POLYSACCHARIDE AND PROTEIN AND PREPARATION METHOD THEREOF | KOROTCHKINA, LIOUBOV G | 1653 | §103§112 | Final Rejection | — | Pending | Jul 25, 2023 |
| 17287642 | DIHYDRAZONE COMPOUNDS HAVING HIGH AFFINITY TO A BETA PROTEIN AND TAU PROTEIN, DERIVATIVES THEREOF AND USE THEREOF | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Non-Final OA | — | Pending | Apr 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBeijing Normal University has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Mehmet Yesildag has the most, with 1 of Beijing Normal University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
